Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA (CATARA)
This study has been withdrawn prior to enrollment.
(decision of sponsor to withdraw before initiation; 0 patients enrolled)
Information provided by (Responsible Party):
Mark Genovese, Stanford University
First received: September 10, 2010
Last updated: February 3, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||December 2011|
|Primary Completion Date:||August 2011 (Final data collection date for primary outcome measure)|